A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction.

Source:http://linkedlifedata.com/resource/pubmed/id/18073226

Download in:

View as

General Info

PMID
18073226